JPH10204082A - 選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ［ｂ］チオフェン化合物 - Google Patents

選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ［ｂ］チオフェン化合物

Info

Publication number
JPH10204082A
JPH10204082A JP9325116A JP32511697A JPH10204082A JP H10204082 A JPH10204082 A JP H10204082A JP 9325116 A JP9325116 A JP 9325116A JP 32511697 A JP32511697 A JP 32511697A JP H10204082 A JPH10204082 A JP H10204082A
Authority
JP
Japan
Prior art keywords
thiophene
benzo
alkyl
benzoyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP9325116A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10204082A5 (OSRAM
Inventor
Kristin Sue Marron
クリスティン・スー・マローン
Christopher Randall Schmid
クリストファー・ランドール・シュミッド
James Patrick Sluka
ジェイムズ・パトリック・スルカ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPH10204082A publication Critical patent/JPH10204082A/ja
Publication of JPH10204082A5 publication Critical patent/JPH10204082A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
JP9325116A 1996-10-25 1997-10-20 選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ［ｂ］チオフェン化合物 Withdrawn JPH10204082A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2905696P 1996-10-25 1996-10-25
US60/029056 1996-10-25

Publications (2)

Publication Number Publication Date
JPH10204082A true JPH10204082A (ja) 1998-08-04
JPH10204082A5 JPH10204082A5 (OSRAM) 2005-06-30

Family

ID=21846972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9325116A Withdrawn JPH10204082A (ja) 1996-10-25 1997-10-20 選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ［ｂ］チオフェン化合物

Country Status (7)

Country Link
US (1) US5962475A (OSRAM)
EP (1) EP0838464B1 (OSRAM)
JP (1) JPH10204082A (OSRAM)
AT (1) ATE249454T1 (OSRAM)
CA (1) CA2218756A1 (OSRAM)
DE (1) DE69724733T2 (OSRAM)
ES (1) ES2206664T3 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE284690T1 (de) 1995-10-31 2005-01-15 Lilly Co Eli Antithrombotische diamine
AU7896100A (en) * 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
WO2001035946A2 (en) * 1999-11-15 2001-05-25 New Millennium Pharmaceutical Research, Inc. Intranasal administration of raloxifene and tamoxifen
EP1278493A4 (en) * 1999-12-29 2006-09-27 Cell Medical Inc X DEVICE AND METHOD FOR ADMINISTERING COMPOUNDS TO LIVING ORGANISM
US6471979B2 (en) 1999-12-29 2002-10-29 Estrogen Vascular Technology, Llc Apparatus and method for delivering compounds to a living organism
AU2002235348A1 (en) * 2001-01-17 2002-07-30 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
PT1383482E (pt) * 2001-05-01 2007-09-20 Pfizer Prod Inc Método para o fabrico de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de fármaco uniforme
WO2002094788A1 (en) 2001-05-22 2002-11-28 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
CA2444787A1 (en) * 2001-05-22 2002-11-28 Eli Lilly And Company Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
PL367094A1 (en) 2001-07-31 2005-02-21 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
EP1530470B9 (en) 2002-07-22 2010-04-07 Eli Lilly And Company Selective estrogen receptor modulators containing a phenylsulfonyl group
HK1208875A1 (en) * 2012-01-12 2016-03-18 耶鲁大学 Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase
ES2774935T3 (es) * 2012-10-24 2020-07-23 Univ Illinois Composiciones y métodos para tratar trastornos médicos relacionados con estrógeno
WO2014066695A1 (en) 2012-10-24 2014-05-01 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating estrogen-related medical disorders
JP6644268B2 (ja) * 2018-03-22 2020-02-12 横浜ゴム株式会社 タイヤ用ゴム組成物及びスタッドレスタイヤ
RS63876B1 (sr) * 2018-07-12 2023-02-28 Lilly Co Eli Selektivni degradatori estrogenskih receptora

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65404A0 (en) * 1981-04-03 1982-07-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US6703407B1 (en) * 1994-09-20 2004-03-09 Eli Lilly And Company Benzofuran compounds, compositions, and methods
US5484798A (en) * 1994-09-20 1996-01-16 Eli Lilly And Company Benzothiopene compounds, compositions, and method of inhibiting restenosis
US5589482A (en) * 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
US5552401A (en) * 1995-02-28 1996-09-03 Eli Lilly And Company 2-benzyl-3-arylbenzothiophenes
US5705507A (en) * 1995-03-10 1998-01-06 Eli Lilly And Company Aplha-substituted-3-benzyl-benzofurans
AU5554996A (en) * 1995-04-21 1996-11-07 Eli Lilly And Company Benzothiophenes with novel basic side chains

Also Published As

Publication number Publication date
EP0838464B1 (en) 2003-09-10
US5962475A (en) 1999-10-05
DE69724733T2 (de) 2004-07-08
ES2206664T3 (es) 2004-05-16
ATE249454T1 (de) 2003-09-15
CA2218756A1 (en) 1998-04-25
EP0838464A1 (en) 1998-04-29
DE69724733D1 (de) 2003-10-16

Similar Documents

Publication Publication Date Title
US5574190A (en) Naphthyl compounds, intermediates, compositions, and methods
US5510357A (en) Benzothiophene compounds as anti-estrogenic agents
CA2228997C (en) Benzothiophene compounds
EP0747377B1 (en) Compounds and compositions with nitrogen-containing non-basic side chains
JPH10204082A (ja) 選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ［ｂ］チオフェン化合物
JP3688299B2 (ja) 五環式化合物、中間体、製法、組成物、および方法
US5811421A (en) Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
US6407243B1 (en) Benzofuran compounds, compositions, and methods
MXPA98000800A (en) Compounds, intermediates of naftilo and dihidronaftilo, compositions and meto
EP0747376B1 (en) Compounds and compositions with nitrogen-containing non-basic side chains
EP0747380B1 (en) Compounds and compositions with nitrogen-containing non-basic side chains
US5952513A (en) Benzo b! thiophene compounds
JPH08268909A (ja) α−置換−１−ベンジルナフチル類
WO1996032937A1 (en) Benzothiophenes with novel basic side chains
EP0791590B1 (en) Benzothiophenes, and formulations and methods using same
US6608090B1 (en) Benzothiophenes with novel basic side chains
JP2006508066A (ja) ジヒドロ−ジベンゾ（ａ）アントラセンの誘導体および選択的エストロゲン受容体モジュレータとしてのその使用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041012

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041012

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20061109